| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
Interleukin-13 receptor subunit alpha-1 serves as a critical component of the IL-13 signaling pathway, forming functional receptor complexes that mediate key immunological responses including allergic inflammation, fibrosis, and tissue remodeling. As a shared subunit between IL-13 and IL-4 receptor systems, IL13RA1 occupies a central position in type 2 immune responses, making it an important target for researchers investigating asthma, atopic diseases, and tumor microenvironment biology. The receptor's designation as cancer/testis antigen 19 further underscores its relevance in oncology research contexts.
This recombinant monoclonal antibody, clone 10E7, offers the reproducibility advantages inherent to sequence-defined reagents. Generated against recombinant human IL13RA1 protein and produced as a human IgG1 format, it eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. Researchers can confidently incorporate this antibody into their workflows knowing that experimental conditions optimized today will translate consistently to future experiments.
Validation studies demonstrate effective performance in immunohistochemistry applications using human tissue samples. Testing in paraffin-embedded human liver tissue using a citrate buffer antigen retrieval protocol at pH 6.0 confirms reliable detection at dilutions ranging from 1:50 to 1:200, providing flexibility to optimize signal intensity based on individual sample characteristics. The antibody is also validated for ELISA applications, supporting quantitative detection workflows.
Supplied in a glycerol-based PBS buffer with Proclin 300 preservative, this affinity-purified antibody is well-suited for immunology and signal transduction research programs exploring IL-13-mediated pathways, receptor biology, or therapeutic target validation studies.
Email: support@cusabio.com
Distributors Worldwide